|
|
 |
|
Total Number of Holdings (excluding cash): 50
| WuXi AppTec Co., Ltd. (Class H) |
2359.HK |
Y971B1118 |
5,685 |
$73,716.86 |
3.57% |
| Smith & Nephew Plc |
SN/.LN |
G82343164 |
2,997 |
$56,087.65 |
2.72% |
| Hoya Corporation |
7741.JP |
J22848105 |
394 |
$51,689.92 |
2.50% |
| ResMed Inc. |
RMD |
761152107 |
177 |
$51,163.62 |
2.48% |
| Insulet Corporation |
PODD |
45784P101 |
148 |
$49,284.00 |
2.39% |
| Mettler-Toledo International Inc. |
MTD |
592688105 |
37 |
$48,724.56 |
2.36% |
| Bio-Rad Laboratories, Inc. (Class A) |
BIO |
090572207 |
160 |
$46,105.60 |
2.23% |
| Koninklijke Philips N.V. |
PHIA.NA |
N7637U112 |
1,655 |
$46,073.46 |
2.23% |
| BioMerieux |
BIM.FP |
F1149Y232 |
303 |
$45,300.80 |
2.19% |
| DexCom, Inc. |
DXCM |
252131107 |
553 |
$45,163.51 |
2.19% |
| Cochlear Limited |
COH.AU |
Q25953102 |
232 |
$45,025.06 |
2.18% |
| Demant A/S |
DEMANT.DC |
K3008M105 |
1,122 |
$44,906.69 |
2.18% |
| West Pharmaceutical Services, Inc. |
WST |
955306105 |
183 |
$45,087.54 |
2.18% |
| Hologic, Inc. |
HOLX |
436440101 |
651 |
$44,762.76 |
2.17% |
| Agilent Technologies, Inc. |
A |
00846U101 |
372 |
$44,308.92 |
2.15% |
| Edwards Lifesciences Corporation |
EW |
28176E108 |
545 |
$44,357.55 |
2.15% |
| Sartorius Stedim Biotech |
DIM.FP |
F8005V210 |
212 |
$44,319.50 |
2.15% |
| GE HealthCare Technologies Inc. |
GEHC |
36266G107 |
597 |
$44,100.39 |
2.14% |
| Danaher Corporation |
DHR |
235851102 |
206 |
$43,548.40 |
2.11% |
| Thermo Fisher Scientific Inc. |
TMO |
883556102 |
87 |
$43,048.47 |
2.09% |
| Siemens Healthineers AG |
SHL.GY |
D6T479107 |
766 |
$42,988.46 |
2.08% |
| Steris Plc |
STE |
G8473T100 |
171 |
$42,673.05 |
2.07% |
| Boston Scientific Corporation |
BSX |
101137107 |
401 |
$42,526.05 |
2.06% |
| Medtronic Plc |
MDT |
G5960L103 |
451 |
$42,042.22 |
2.04% |
| Stryker Corporation |
SYK |
863667101 |
107 |
$41,930.09 |
2.03% |
| Fisher & Paykel Healthcare Corporation Limited |
FPH.NZ |
Q38992105 |
1,881 |
$41,263.01 |
2.00% |
| Exact Sciences Corporation |
EXAS |
30063P105 |
850 |
$39,950.00 |
1.94% |
| Abbott Laboratories |
ABT |
002824100 |
299 |
$39,599.56 |
1.92% |
| Straumann Holding AG (Registered) |
STMN.SW |
H8300N127 |
321 |
$38,344.31 |
1.86% |
| Zimmer Biomet Holdings, Inc. |
ZBH |
98956P102 |
364 |
$38,478.44 |
1.86% |
| Sonova Holding AG (Registered) |
SOON.SW |
H8024W106 |
132 |
$38,220.89 |
1.85% |
| Becton, Dickinson and Company |
BDX |
075887109 |
187 |
$37,250.40 |
1.80% |
| Revvity, Inc. |
RVTY |
714046109 |
400 |
$36,680.00 |
1.78% |
| Intuitive Surgical, Inc. |
ISRG |
46120E602 |
76 |
$36,514.20 |
1.77% |
| The Cooper Companies, Inc. |
COO |
216648501 |
493 |
$36,235.50 |
1.76% |
| Teleflex Incorporated |
TFX |
879369106 |
288 |
$36,187.20 |
1.75% |
| Masimo Corporation |
MASI |
574795100 |
246 |
$35,829.90 |
1.74% |
| Coloplast A/S (Class B) |
COLOB.DC |
K16018192 |
360 |
$35,436.99 |
1.72% |
| Merit Medical Systems, Inc. |
MMSI |
589889104 |
406 |
$35,468.16 |
1.72% |
| Penumbra, Inc. |
PEN |
70975L107 |
138 |
$35,289.36 |
1.71% |
| Olympus Corporation |
7733.JP |
J61240107 |
2,940 |
$35,048.82 |
1.70% |
| Waters Corporation |
WAT |
941848103 |
118 |
$35,014.14 |
1.70% |
| Alcon Inc. |
ALC.SW |
H01301128 |
428 |
$34,900.09 |
1.69% |
| Terumo Corporation |
4543.JP |
J83173104 |
1,860 |
$34,898.56 |
1.69% |
| Amplifon SpA |
AMP.IM |
T0388E118 |
1,873 |
$33,350.16 |
1.62% |
| Align Technology, Inc. |
ALGN |
016255101 |
232 |
$33,310.56 |
1.61% |
| Baxter International Inc. |
BAX |
071813109 |
1,322 |
$32,084.94 |
1.55% |
| Globus Medical, Inc. (Class A) |
GMED |
379577208 |
524 |
$31,822.52 |
1.54% |
| Carl Zeiss Meditec AG (Bearer) |
AFX.GY |
D14895102 |
624 |
$31,034.54 |
1.50% |
| Sysmex Corporation |
6869.JP |
J7864H102 |
1,934 |
$25,891.15 |
1.25% |
| US Dollar |
$USD |
|
7,211 |
$7,211.33 |
0.35% |
| Euro |
$EUR |
|
0 |
$0.06 |
0.00% |
| Pound Sterling |
$GBP |
|
0 |
$0.15 |
0.00% |
Holdings are subject to change.
The holdings information set forth above for the date indicated reflects creation and redemption transactions from the prior business day and may differ from the holdings information currently available from the Fund's custodian and accounting agent. With respect to the market value of the Fund's holdings set forth above, the pricing sources are generally third party vendors. The Fund ultimately relies on pricing information provided by the Fund's accounting agent.
|
|
The information presented is not intended to constitute an investment recommendation for, or advice to, any specific person. By providing this information, First Trust is not undertaking to give advice in any fiduciary capacity within the meaning of ERISA, the Internal Revenue Code or any other regulatory framework. Financial professionals are responsible for evaluating investment risks independently and for exercising independent judgment in determining whether investments are appropriate for their clients.
|